메뉴 건너뛰기




Volumn 24, Issue 1, 2013, Pages 85-89

Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies

Author keywords

autoantibody; autoimmune disease; factor XIII deficiency; fatal bleeding disorder; point of care test

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 ANTIBODY; CEFTRIAXONE; FRESH FROZEN PLASMA; HEMOGLOBIN; PREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

EID: 84871807326     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328358e8e7     Document Type: Article
Times cited : (13)

References (15)
  • 1
    • 14544291028 scopus 로고    scopus 로고
    • Extracellular transglutaminase: Factor XIII
    • Ichinose A. Extracellular transglutaminase: factor XIII. Prog Exp Tumor Res 2005; 38:192-208.
    • (2005) Prog Exp Tumor Res , vol.38 , pp. 192-208
    • Ichinose, A.1
  • 2
    • 79960076132 scopus 로고    scopus 로고
    • Factor XIII: A coagulation factor with multiple plasmatic and cellular functions
    • Muszbek L, Bereczky Z, Bagoly Z, Komá romi I, Katona E. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011; 91:931-972.
    • (2011) Physiol Rev , vol.91 , pp. 931-972
    • Muszbek, L.1    Bereczky, Z.2    Bagoly, Z.3    Komáromi, I.4    Katona, E.5
  • 3
    • 79955776731 scopus 로고    scopus 로고
    • As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan
    • Ichinose A, Souri M, Japanese collaborative research group on 'Acquired haemorrha-philia due to factor XIII deficiency'. As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan. Thromb Haemost 2011; 105:925-927.
    • (2011) Thromb Haemost , vol.105 , pp. 925-927
    • Ichinose, A.1    Souri, M.2
  • 4
    • 79961066578 scopus 로고    scopus 로고
    • Hemorrhagic acquired factor xiii (13) deficiency and acquired hemorrhaphilia 13 revisited
    • Ichinose A. Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited. Semin Thromb Hemost 2011; 37:382-388.
    • (2011) Semin Thromb Hemost , vol.37 , pp. 382-388
    • Ichinose, A.1
  • 6
    • 33847411624 scopus 로고    scopus 로고
    • Acquired hemophilia A in the United Kingdom: A 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' organisation
    • DOI 10.1182/blood-2006-06-029850
    • Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, for the UK Haemophilia Centre Doctors' Organisation. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007; 109:1870-1877. (Pubitemid 46348182)
    • (2007) Blood , vol.109 , Issue.5 , pp. 1870-1877
    • Collins, P.W.1    Hirsch, S.2    Baglin, T.P.3    Dolan, G.4    Hanley, J.5    Makris, M.6    Keeling, D.M.7    Liesner, R.8    Brown, S.A.9    Hay, C.R.M.10
  • 7
    • 84857632288 scopus 로고    scopus 로고
    • Reduced difference of a(2)-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to antifactor XIII antibodies
    • Ichinose A, Souri M. Reduced difference of a(2)-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to antifactor XIII antibodies. Int J Hematol 2012; 55:47-50.
    • (2012) Int J Hematol , vol.55 , pp. 47-50
    • Ichinose, A.1    Souri, M.2
  • 8
    • 41849131483 scopus 로고    scopus 로고
    • Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice
    • Souri M, Koseki-Kuno S, Takeda N, Degen JL, Ichinose A. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice. Int J Hematol 2008; 87:60-68.
    • (2008) Int J Hematol , vol.87 , pp. 60-68
    • Souri, M.1    Koseki-Kuno, S.2    Takeda, N.3    Degen, J.L.4    Ichinose, A.5
  • 9
    • 79960143603 scopus 로고    scopus 로고
    • Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Pathology consultation on drug-induced hemolytic anemia
    • Pierce A, Nester T, Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Pathology consultation on drug-induced hemolytic anemia. Am J Clin Pathol 2011; 136:7-12.
    • (2011) Am J Clin Pathol , vol.136 , pp. 7-12
    • Pierce, A.1    Nester, T.2
  • 10
    • 77955415920 scopus 로고    scopus 로고
    • Immune hemolytic anemia associated with drug therapy
    • Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010; 24:143-150.
    • (2010) Blood Rev , vol.24 , pp. 143-150
    • Garratty, G.1
  • 11
    • 22544464411 scopus 로고    scopus 로고
    • The changing spectrum of drug-induced immune hemolytic anemia
    • DOI 10.1053/j.seminhematol.2005.04.004, PII S0037196305000570
    • Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 2005; 42:137-144. (Pubitemid 41019442)
    • (2005) Seminars in Hematology , vol.42 , Issue.3 , pp. 137-144
    • Arndt, P.A.1    Garratty, G.2
  • 12
    • 0025872609 scopus 로고
    • Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia
    • Krumdieck R, Shaw DR, Huang ST, Poon MC, Rustagi PK. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia. Am J Med 1991; 90:639-645.
    • (1991) Am J Med , vol.90 , pp. 639-645
    • Krumdieck, R.1    Shaw, D.R.2    Huang, S.T.3    Poon, M.C.4    Rustagi, P.K.5
  • 13
    • 18844402183 scopus 로고    scopus 로고
    • Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin
    • Miesbach W. Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin. Thromb Haemost 2005; 93:1001-1003. (Pubitemid 40691564)
    • (2005) Thrombosis and Haemostasis , vol.93 , Issue.5 , pp. 1001-1003
    • Miesbach, W.1    Boehm, M.2    Scharrer, I.3
  • 14
    • 84862854584 scopus 로고    scopus 로고
    • Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control
    • Ichinose A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control. Int J Hematol 2012; 95:362-370.
    • (2012) Int J Hematol , vol.95 , pp. 362-370
    • Ichinose, A.1
  • 15
    • 18844381129 scopus 로고    scopus 로고
    • Acquired factor XIII deficiency due to an inhibitor: A case report and review of the literature
    • Nijenhuis AV, van Bergeijk L, Huijgens PC, Zweegman S. Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature. Haematologica 2004; 89:e46-e48.
    • (2004) Haematologica , vol.89
    • Nijenhuis, A.V.1    Van Bergeijk, L.2    Huijgens, P.C.3    Zweegman, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.